Home » Topics » Science » New compound

New compound
RSS

CPI-381: a first-in-class TREX1 inhibitor with antitumor activity in preclinical models

Nov. 16, 2021

LPAR1 antagonist PIPE-791 promotes remyelination in multiple sclerosis

Nov. 15, 2021

Cannabigerol derivatives have anti-inflammatory, analgesic and antiobesity potential

Nov. 12, 2021

Trivalent PROTAC SIM-1 shows enhanced BET degradation and cytotoxicity

Nov. 11, 2021

SUVN-4404091 shows efficacy in rat model of amphetamine-induced hyperlocomotion

Nov. 11, 2021

Effective attenuation of renal fibrosis with a potent HIPK2 inhibitor

Nov. 10, 2021

Viking Therapeutics' dual GLP-1/GIP receptor agonists show potential in model of obesity

Nov. 8, 2021

Discovery of HB-007, a small-molecule degrader of SUMO1

Nov. 5, 2021

MM-3122, a novel TMPRSS2 inhibitor with antiviral activity against SARS-CoV-2 and MERS-CoV

Nov. 5, 2021

Structure-based optimization identifies potent galactokinase inhibitors

Nov. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...